We studied the clinical and neurophysiological effects of methylcobalamin on patients with diabetic neuropathy. In a double-blind study, the active group showed statistical improvement in the somatic and autonomic symptoms with regression of signs of diabetic neuropathy. Motor and sensory nerve conduction studies showed no statistical improvement after 4 months. The drug was easily tolerated by the patients and no side effects were encountered.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/0303-8467(92)90066-c | DOI Listing |
Publication Analysis
Top Keywords
diabetic neuropathy
12
effects methylcobalamin
8
statistical improvement
8
methylcobalamin diabetic
4
neuropathy studied
4
studied clinical
4
clinical neurophysiological
4
neurophysiological effects
4
methylcobalamin patients
4
patients diabetic
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!